AIM ImmunoTech Secures Key Patent for Post-COVID Fatigue Drug Ampligen Following Promising Trial Data – StockTitan
AIM ImmunoTech Secures Key Patent for Post-COVID Fatigue Drug Ampligen Following Promising Trial Data StockTitan
In: PATENT NEWS
AIM ImmunoTech Secures Key Patent for Post-COVID Fatigue Drug Ampligen Following Promising Trial Data StockTitan
In: PATENT NEWS
Six more HMD related Patents from Apple were published today covering Flexible Speakers, Light Output and more Patently Apple
In: PATENT NEWS
Dexcom suffers third successive patent loss in Abbott UPC dispute IAM
In: PATENT NEWS
The role of Italian law firms in UPC litigation JUVE Patent
In: PATENT NEWS
Oneida Express Girls basketball beats Holland Patent 41-35 Oneida Dispatch
In: PATENT NEWS
Visionary Entrepreneur Patents World’s First Non-Depreciating Crypto Asset By Chainwire Investing.com
In: PATENT NEWS
Clarivate Launches AI-Powered Patent Search Solution In Derwent Barchart
In: PATENT NEWS
Clarivate Unveils Game-Changing AI Patent Search Tool, Revolutionizing Innovation Research StockTitan
In: PATENT NEWS
Clarivate Launches AI-Powered Patent Search Solution in Derwent PR Newswire
In: PATENT NEWS
The past year introduced significant legal and technological advancements that impacted intellectual property (IP) rights, presenting both …
Designed by Industrial Action
Copyright © 2025 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION